StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JPMorgan Resumes Alkermes (ALKS) at Neutral
July 13, 2026 3:13 AM
JPMorgan analyst Jessica Fye resumes coverage on Alkermes (NASDAQ: ALKS) with a Neutral rating and a price target of $60.00.The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
New Coverage